Microbiology & Immunology | Faculty
<Department of Microbiology & Immunology, UT Health Science Center at San Antonio Double Helix rotating/>

 

Departmental Primary Faculty and their Research Programs

*Members of the Graduate Faculty are available as mentors to graduate students.

*Joel B. Baseman, Ph.D.

Host-mycoplasma interplay; Mechanisms of cytadherence; Invasion; Intracellular persistence; Molecular basis of virulence; Toxin-mediated cytopathology; Gene regulation

*Molly Bergman, Ph.D.

Host-pathogen interactions; Yersinia pseudotuberculosis, CD8+ T cell responses; apoptosis; phagocytosis, gastrointestinal infection

*Michael T. Berton, Ph.D.

Cytokine and Toll-like receptor signaling; immunity to infection; Francisella tularensis; interleukin-4

*Santanu Bose, Ph.D.

Host antiviral defense mechanism: innate immune antiviral and inflammatory response against respiratory RNA viruses like human respiratory syncytial virus (RSV), influenza A virus and parainfluenza viruses; virus based anti-cancer therapeutics.

*Subramanian Dhandayuthapani, Ph.D.

Molecular basis of host-pathogen interaction; stress signaling and regulation of gene expression in Mycobacterium tuberculosis and Mycoplasma genitalium

*Peter H. Dube, Ph.D.

Bacterial host-pathogen interaction in vivo; inflammation; cytokine response; Yersinia; asthma, inflammatory T-cell responses

*William G. Haldenwang, Ph.D.

Molecular genetics; bacterial sporulation; RNA polymerase biochemistry

*David Kadosh, Ph.D.

Control of filamentous growth and virulence in the major fungal pathogen Candida albicans; identification and characterization of novel C. albicans virulence factors; transcriptional regulation; C. albicans genomics

*David J. Kolodrubetz, Ph.D.

Bacterial genetics; virulence mechanisms in periodontal pathogens; transcriptional regulation; function of microbial surface layer proteins

*Keith A. Krolick, Ph.D.

Immunobiology; Autoimmune disease; Two-way communication between the immune system and autoimmune target tissues; Immune and muscle responses in Myasthenia Gravis

*Carlos J. Orihuela, Ph.D.

Use of comparative genomics to identify differences between invasive and non-invasive clinical isolates of Streptococcus pneumoniae; Identification of novel virulence determinants and assessment of their vaccine potential

*Brian L. Wickes, Ph.D.

Medical mycology; molecular mechanisms of fungal pathogenesis, mating and development in Cryptococcus neoformans, Candida albicans biofilms molecular biology, animal models of invasive aspergillosis

*Yan Xiang, Ph.D.

Poxvirus pathogenesis and immune modulation; virus-host interactions; protein structure-function

*Guangming Zhong, M.D., Ph.D.

Molecular basis of Chlamydia-host interactions; Chlamydiae pneumoniae in atherosclerosis; Proteomics analysis of chlamydial hypothetical proteins; Vaccine development



[return to top]

 

Faculty with Primary Appointments in other Departments

*Sunil K. Ahuja, M.D.

Role of chemokine and chemokine receptors in immune system development, defense against chronic or infectious diseases, and HIV-1 pathogenesis

Bernard P. Arulanandam, Ph.D., M.B.A.

The identification of novel therapeutic/prophylactic vaccine strategies and combinatorial antimicrobial therapies are of continued interest in the field of public health.

*Garry T. Cole, Ph.D.

Development of human and veterinary vaccines against fungal diseases

*Shou-Jiang Gao, Ph.D.

Viral oncogenesis, herpesvirus latency and reactivation, Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) pathogenesis and molecular epidemiology

*Luis D. Giavedoni, Ph.D.

Innate and adaptive immune responses to vaccines and viral infections; SIV pathogenesis and vaccine development

*Anthony Griffiths, Ph.D.

Herpesvirus latency and pathogenesis; herpes B virus; zoonoses; microRNAs; vaccine development; antiviral agents; BSL-4

*M. Neal Guentzel, Ph.D.

Public health microbiology; enteric bacteriology

*Andrew Hayhurst , Ph.D.

Work in my laboratory is primarily concerned with developing disruptive technologies for the detection and inhibition of high consequence pathogens and toxins.

*Anthony J. Infante, M.D., Ph.D.

Immunology; T cell receptor repertoires in health and disease; autoimmunity; immunodeficiency states

*James H. Jorgensen, Ph.D.

Clinical microbiology; mechanisms of antimicrobial resistance and their detection in clinical isolates; new antimicrobial agents

*Karl E. Klose, Ph.D.

Molecular mechanisms of Vibrio cholerae and Francisella tularensis pathogenesis; transcription regulation; biodefense and food-borne disease vaccine development

*Ellen Kraig, Ph.D.

Molecular immunology; autoimmunity; bacterial pathogenesis

*Robert E. Lanford, Ph.D.

Molecular biology and pathogenesis hepatitis B virus, and hepatitis C virus

*Peter C. Melby, M.D.

Immunopathogenic mechanisms and protective immunity; in leishmaniasis

*Jean L. Patterson, Ph.D.

Molecular Biology of RNA viruses and development of Anthrax therapeutics

Jose L. Lopez-Ribot, Ph.D.

My laboratory studies the opportunistic pathogenic fungus Candida albicans.

*Judy M. Teale, Ph.D.

Immunobiology, immunology and pathogenesis of neurocysticercosis, immune response to Francisella tularensis

[return to top]